{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:20:33Z","timestamp":1780446033946,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T00:00:00Z","timestamp":1436832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/gt.2015.62","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T14:54:55Z","timestamp":1436885695000},"page":"876-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice"],"prefix":"10.1038","volume":"22","author":[{"given":"R","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Buras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Espiritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Nally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Yechoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"BFgt201562_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson MS, Bluestone JA . The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005; 23: 447\u2013485.","journal-title":"Annu Rev Immunol"},{"key":"BFgt201562_CR2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone JA, Herold K, Eisenbarth G . Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464: 1293\u20131300.","journal-title":"Nature"},{"key":"BFgt201562_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-065X.2008.00659.x","volume":"224","author":"ID Dimitriou","year":"2008","unstructured":"Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R . Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224: 265\u2013283.","journal-title":"Immunol Rev"},{"key":"BFgt201562_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","volume":"19","author":"BA Croker","year":"2008","unstructured":"Croker BA, Kiu H, Nicholson SE . SOCS regulation of the JAK\/STAT signalling pathway. Semin Cell Dev Biol 2008; 19: 414\u2013422.","journal-title":"Semin Cell Dev Biol"},{"key":"BFgt201562_CR5","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.3760\/cma.j.issn.0366-6999.20130557","volume":"126","author":"Q Sun","year":"2013","unstructured":"Sun Q, Xiang RL, Yang YL, Feng K, Zhang K, Ding WY . Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase\/signal transducers and activators of transcription pathway. Chin Med J (Engl) 2013; 126: 4048\u20134053.","journal-title":"Chin Med J (Engl)"},{"key":"BFgt201562_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni771","volume":"3","author":"M Flodstrom","year":"2002","unstructured":"Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N . Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3: 373\u2013382.","journal-title":"Nat Immunol"},{"key":"BFgt201562_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/01.TP.0000162979.66954.53","volume":"79","author":"M Solomon","year":"2005","unstructured":"Solomon M, Flodstrom-Tullberg M, Sarvetnick N . Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB\/c and spontaneously-diabetic NOD recipient mice. Transplantation 2005; 79: 1104\u20131109.","journal-title":"Transplantation"},{"key":"BFgt201562_CR8","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.4049\/jimmunol.172.9.5714","volume":"172","author":"MM Chong","year":"2004","unstructured":"Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P et al. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J Immunol 2004; 172: 5714\u20135721.","journal-title":"J Immunol"},{"key":"BFgt201562_CR9","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.2337\/diabetes.52.11.2696","volume":"52","author":"M Flodstrom-Tullberg","year":"2003","unstructured":"Flodstrom-Tullberg M, Yadav D, Hagerkvist R, Tsai D, Secrest P, Stotland A et al. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes 2003; 52: 2696\u20132700.","journal-title":"Diabetes"},{"key":"BFgt201562_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trim.2010.11.007","volume":"24","author":"M Solomon","year":"2011","unstructured":"Solomon M, Flodstrom-Tullberg M, Sarvetnick N . Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling. Transpl Immunol 2011; 24: 181\u2013188.","journal-title":"Transpl Immunol"},{"key":"BFgt201562_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1055\/s-0033-1353165","volume":"121","author":"GJ Suo","year":"2013","unstructured":"Suo GJ, Zhao ZX . Xenogeneic islet transplantation of Ad5F35-SOCS1 infected islets for therapy of diabetes. Exp Clin Endocrinol Diabetes 2013; 121: 521\u2013525.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFgt201562_CR12","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.transproceed.2010.04.039","volume":"42","author":"GJ Suo","year":"2010","unstructured":"Suo GJ, Qin J, Zhong CP, Zhao ZX . Suppressor of cytokine signaling 1 inhibits apoptosis of islet grafts through caspase 3 and apoptosis-inducing factor pathways in rats. Transplant Proc 2010; 42: 2658\u20132661.","journal-title":"Transplant Proc"},{"key":"BFgt201562_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1210\/er.2008-0006","volume":"29","author":"X Huang","year":"2008","unstructured":"Huang X, Moore DJ, Ketchum RJ, Nunemaker CS, Kovatchev B, McCall AL et al. Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev 2008; 29: 603\u2013630.","journal-title":"Endocr Rev"},{"key":"BFgt201562_CR14","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2337\/db07-0460","volume":"56","author":"Y Lee","year":"2007","unstructured":"Lee Y, Ravazzola M, Park BH, Bashmakov YK, Orci L, Unger RH . Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin. Diabetes 2007; 56: 2295\u20132301.","journal-title":"Diabetes"},{"key":"BFgt201562_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ecl.2010.05.010","volume":"39","author":"RP Robertson","year":"2010","unstructured":"Robertson RP . Update on transplanting beta cells for reversing type 1 diabetes. Endocrinol Metab Clin North Am 2010; 39: 655\u2013667.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFgt201562_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","volume":"355","author":"AM Shapiro","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318\u20131330.","journal-title":"N Engl J Med"},{"key":"BFgt201562_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.devcel.2009.01.012","volume":"16","author":"V Yechoor","year":"2009","unstructured":"Yechoor V, Liu V, Espiritu C, Paul A, Oka K, Kojima H et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell 2009; 16: 358\u2013373.","journal-title":"Dev Cell"},{"key":"BFgt201562_CR18","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1210\/en.2009-0527","volume":"150","author":"V Yechoor","year":"2009","unstructured":"Yechoor V, Liu V, Paul A, Lee J, Buras E, Ozer K et al. Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in Insulin-deficient diabetic mice. Endocrinology 2009; 150: 4863\u20134873.","journal-title":"Endocrinology"},{"key":"BFgt201562_CR19","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","volume":"24","author":"K Ueki","year":"2004","unstructured":"Ueki K, Kondo T, Kahn CR . Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004; 24: 5434\u20135446.","journal-title":"Mol Cell Biol"},{"key":"BFgt201562_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2337\/db09-1846","volume":"59","author":"RP Robertson","year":"2010","unstructured":"Robertson RP . Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes 2010; 59: 1285\u20131291.","journal-title":"Diabetes"},{"key":"BFgt201562_CR21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.transproceed.2010.04.021","volume":"42","author":"RM Langer","year":"2010","unstructured":"Langer RM . Islet transplantation: lessons learned since the Edmonton breakthrough. Transplant Proc 2010; 42: 1421\u20131424.","journal-title":"Transplant Proc"},{"key":"BFgt201562_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1740-2557-1-3","volume":"1","author":"MT Tabiin","year":"2004","unstructured":"Tabiin MT, White CP, Morahan G, Tuch BE . Insulin expressing hepatocytes not destroyed in transgenic NOD mice. J Autoimmune Dis 2004; 1: 3.","journal-title":"J Autoimmune Dis"},{"key":"BFgt201562_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaut.2007.02.010","volume":"28","author":"K Shternhall-Ron","year":"2007","unstructured":"Shternhall-Ron K, Quintana FJ, Perl S, Meivar-Levy I, Barshack I, Cohen IR et al. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun 2007; 28: 134\u2013142.","journal-title":"J Autoimmun"},{"key":"BFgt201562_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.2337\/db06-0109","volume":"55","author":"NL Dudek","year":"2006","unstructured":"Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E et al. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 2006; 55: 2412\u20132418.","journal-title":"Diabetes"},{"key":"BFgt201562_CR25","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1089\/10430349950016708","volume":"10","author":"P Ng","year":"1999","unstructured":"Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL . A high-efficiency Cre\/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 1999; 10: 2667\u20132672.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201562","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T23:46:21Z","timestamp":1717976781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFgt201562"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.62","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]},"assertion":[{"value":"1 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}